TERT and cancer: The implication is that the TERT promoter mutation may disrupt the function of the telomere in ways other than by simply increasing its length, as evidenced by findings of common variants that affect cancer risk but not directly via telomere length [20] Alternatively the effect on telomere length may be tissue-specific and the effect differs between melanocytic and lymphocytic.